Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Monitoring of minimal residual disease (MRD) has become routine clinical practice in frontline treatment of virtually all childhood acute lymphoblastic leukemia (ALL) and in many adult ALL patients. MRD diagnostics has proven to be the strongest prognostic factor, allowing for risk group assignment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: van Dongen, Jacques J. M., van der Velden, Vincent H. J., Brüggemann, Monika, Orfao, Alberto
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2015
Materias:
Review Series
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490298/
https://ncbi.nlm.nih.gov/pubmed/25999452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-580027
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares